Flavonoid constituents of Amomum tsao-ko Crevost et Lemarie and their antioxidant and antidiabetic effects in diabetic rats - in vitro and in vivo studies
Crevost et Lemarie ( ) is a well-known dietary spice and traditional Chinese medicine. This study aimed to identify the flavonoids in and evaluate their antioxidant and antidiabetic activities in and studies. methanol extracts possessed a high flavonoid content (1.21 mg QE per g DW) and a total of 2...
Gespeichert in:
Veröffentlicht in: | Food & function 2022-01, Vol.13 (1), p.437-450 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Crevost et Lemarie (
) is a well-known dietary spice and traditional Chinese medicine. This study aimed to identify the flavonoids in
and evaluate their antioxidant and antidiabetic activities in
and
studies.
methanol extracts possessed a high flavonoid content (1.21 mg QE per g DW) and a total of 29 flavonoids were identified by employing UPLC-MS/MS.
,
demonstrated antioxidant activity (ORAC value of 34276.57 μM TE/100 g DW, IC
of ABTS of 3.49 mg mL
and FRAP value of 207.42 μM Fe
per g DW) and α-amylase and α-glucosidase inhibitory ability with IC
values of 14.23 and 1.76 mg mL
, respectively.
, type 2 diabetes mellitus (T2DM) models were induced by a combined high-fat diet (HFD) and streptozotocin (STZ) injection in rats. Treatment with the
extract (100 mg freeze-dried powder per kg bw) for 6 weeks could significantly improve impaired glucose tolerance, decrease the levels of fasting blood glucose (FBG), insulin, and malondialdehyde (MDA), and increase the superoxide dismutase (SOD) level. Histopathology revealed that the
extract preserved the architecture and function of the pancreas. In conclusion, the flavonoid composition of
exhibits excellent antioxidant and antidiabetic activity
and
.
could be a novel natural material and developed as a related functional food and medicine in T2DM management. |
---|---|
ISSN: | 2042-6496 2042-650X 2042-650X |
DOI: | 10.1039/d1fo02974f |